Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study
about
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Validation of the OncoMasTR Ri ...... ve Patients: A TransATAC study
@en
type
label
Validation of the OncoMasTR Ri ...... ve Patients: A TransATAC study
@en
prefLabel
Validation of the OncoMasTR Ri ...... ve Patients: A TransATAC study
@en
P2093
P50
P1476
Validation of the OncoMasTR Ri ...... ve Patients: A TransATAC study
@en
P2093
Bozena Fender
Cesar Lopez Ruiz
Des O'Leary
Ivana Sestak
Mitch Dowsett
Stephen Barron
P304
P356
10.1158/1078-0432.CCR-19-0712
P577
2019-10-22T00:00:00Z